Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1999
11/03/1999EP0655069B1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
11/03/1999EP0637986B1 Method and device for treating a parenteral emulsion-containing medicament fluid
11/03/1999EP0596984B1 Preparation of microparticles
11/03/1999EP0535200B1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
11/03/1999CN1233967A Device and method for enhancing transdermal agent flux
11/03/1999CN1233964A Anti-carious chewing gums, candies, gels, toothpaste and dentifrices
11/03/1999CN1233963A Ophthalmic compositions of neurotrophic factor, remedies for optic nerve function disorders and method for treating same
11/03/1999CN1233962A Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same
11/03/1999CN1233960A Chlorofluorocarbon-free mometasone furoate aerosol formulations
11/03/1999CN1233959A Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their prepn.
11/03/1999CN1233954A Taste-masked microcapsule compositions and method for mfg. same
11/03/1999CN1233953A Ascending-dose dosage form
11/03/1999CN1233952A Nasal administration of desmopressin
11/03/1999CN1233586A Precipitated silica granules
11/03/1999CN1233501A Traditional Chinese medicinal prepns. for treating hepatitis B virus, and method for preparing same
11/03/1999CN1233500A Nasal cavity paste for preventing influenza
11/03/1999CN1233494A Infantile plaster for relieving cough
11/03/1999CN1233486A Health-care products made of lotus seed plumule
11/03/1999CN1233478A Method for preparing plaster for removing obstruction in the channel to relieve teeth pain
11/03/1999CN1233476A Medicine for treating acute leukemia, and method for preparing same
11/03/1999CN1233474A Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/03/1999CN1233472A Toxin decontaminant food product and method of forming same
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/03/1999CN1046094C Use of holoside for preparing in-site gelate, ophthalmic composition
11/03/1999CN1046089C Antithyroid cream for external application
11/02/1999US5977180 Anandamide analog compositions and method of treating intraocular hypertension using same
11/02/1999US5977175 Methods and compositions for improving digestion and absorption in the small intestine
11/02/1999US5977172 Prostaglandins, stability
11/02/1999US5977171 Sustained release emulsions
11/02/1999US5977166 Enhanced flavors using menthone ketals
11/02/1999US5977164 Antitumor
11/02/1999US5977158 Pharmaceutical formulations comprising levormeloxifene compounds
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977127 Water soluble stabilizing acid additive whose pks value falls within a given range, such as citric acid or absorbic acid in specific molar ratio
11/02/1999US5977087 Topical preparation for treatment of aphthous ulcers and other lesions
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5977082 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
11/02/1999US5977070 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
11/02/1999US5977069 Mixture of growth hormone and asparagine as stabilizer
11/02/1999US5977066 Oral administering mixture containing glycerides and reaction product of hydrogenated castor oil and ethylene glycol
11/02/1999US5976780 Encapsulated cell device
11/02/1999US5976604 Mixture of sucrose fatty acid ester, water and oil
11/02/1999US5976578 Mixture of antacid, preservative, buffer in aqueous vehicle
11/02/1999US5976577 Process for preparing fast dispersing solid oral dosage form
11/02/1999US5976576 Active material is n-4-(1h-tetrazol-5-yl)phenyl-4-(1h-tetrazol-5-yl)benzamide, disodium salt
11/02/1999US5976575 Dry carotenoid-oil powder and process for making same
11/02/1999US5976574 Forming a suspension; spray drying
11/02/1999US5976573 Aqueous-based pharmaceutical composition
11/02/1999US5976571 Method for making a multi-stage drug delivery system
11/02/1999US5976570 Aqueous solution containing surfactants; granulation
11/02/1999US5976569 Diketopiperazine-based delivery systems
11/02/1999US5976567 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
11/02/1999US5976566 Non-steroidal antiinflammtory drug formulations for topical application to the skin
11/02/1999US5976565 Device for topical treatment of acne and its method of manufacture
11/02/1999US5976561 The principal ingredient is benzalkonium chloride in a water soluble gel which includes sorbitol, glycerin, hydroxethylcellulose and propylene glycol.
11/02/1999US5976560 Products suitable for application to the skin. it is comprised ofvegetable oil and silica.
11/02/1999US5976547 Extract of arnica montana in combination with menthol crystal, camphor, oil of mint, eucalyptus oil, guaifenesin, lidocaine blended in either a pluronic lecithin organogel or a petrolatum base.
11/02/1999US5976521 Anti-acne cosmetic compositions
11/02/1999US5976507 At least one of the active ingredients is a calcium salt or fluoride salt contained in a capsule being formed from a plasticized alkyl cellulose polymer.
11/02/1999US5976505 Method for cryogenically treating psoriasis with liquid nitrogen or liquid nitrous oxide
11/02/1999US5976504 Topical aerosol formulation for cooling of mammalian tissues
11/02/1999CA2185424C Process for making solid dose forms containing bismuth
11/02/1999CA2148465C Oral pharmaceutical preparation releasable in the lower digestive tract
11/02/1999CA2112651C Excipient having high compactability and process for preparing same
10/1999
10/28/1999WO1999054784A1 Free-form nanofabrication using multi-photon excitation
10/28/1999WO1999054344A1 Composition comprising a combination of derivatised cationic liposomes and active agent
10/28/1999WO1999053969A1 Preparation for regenerating collagen
10/28/1999WO1999053947A1 Th2-MIGRATION PROMOTERS CONTAINING W/O EMULSIONS
10/28/1999WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999WO1999053941A1 Oral preparations containing trh derivatives
10/28/1999WO1999053929A1 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
10/28/1999WO1999053923A1 Pharmaceutical composition
10/28/1999WO1999053920A1 Use of vitamin pp compounds
10/28/1999WO1999053918A1 Stabilized compositions containing benzimidazole-type compounds
10/28/1999WO1999053913A1 Topical formulations for the treatment of nail fungal diseases
10/28/1999WO1999053906A1 Adhesive preparations
10/28/1999WO1999053905A1 Multiple-unit sustained release tablets
10/28/1999WO1999053904A2 Softgel-compatible composition containing retinol
10/28/1999WO1999053903A1 Microspheres containing condensed polyanionic bioactive agents and methods for their production
10/28/1999WO1999053902A1 Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
10/28/1999WO1999053901A1 Pharmaceutical aerosol formulation
10/28/1999WO1999053900A1 Drug delivery of proteins from polymeric blends
10/28/1999WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999WO1999053898A1 Implants for administering substances and methods of producing implants
10/28/1999WO1999053897A2 Topical formulation comprising poloxamers and further microbicides, and an applicator
10/28/1999WO1999053754A1 Subversion of bacterial resistance by low solubility antibiotics
10/28/1999WO1999044588A3 Method for producing solid, spherical forms containing pharmaceutical active agents in a binder matrix
10/28/1999WO1999039740A3 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
10/28/1999WO1999039691A3 Pharmaceutical compositions
10/28/1999WO1999037282A3 Reduced lipid flowable cosmetic or dermatological preparations
10/28/1999WO1999034832A8 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
10/28/1999WO1999033846A3 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999DE19818802A1 Stable mitoxantron solutions useful for cancer therapy
10/28/1999DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
10/28/1999CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999CA2328949A1 Adhesive preparations
10/28/1999CA2328882A1 Pharmaceutical aerosol formulation
10/28/1999CA2328154A1 Multiple-unit sustained release tablets
10/28/1999CA2325553A1 Topical formulations for the treatment of nail fungal diseases
1 ... 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 ... 2991